---
layout: report
type: weekly
topic_slug: chronic_migraine
topic_display: "Chronic Migraine"
week_start: 2025-08-25
week_end: 2025-08-31
permalink: /topics/chronic_migraine/weekly/2025-08-25/
source_run_ids:
  - chronic_migraine_20250826_091029
  - chronic_migraine_20250827_091408
  - chronic_migraine_20250828_091013
  - chronic_migraine_20250829_141515
  - chronic_migraine_20250830_090920
topics_covered:
  - Chronic Migraine
---

# Weekly Research Summary: Chronic Migraine

**Disclaimer:** This summary is generated by an AI assistant and is for informational purposes only. It is not a substitute for professional medical advice. Always consult with a qualified healthcare provider for any health concerns or before making any decisions related to your health or treatment.

---

### **TL;DR: Key Takeaways This Week**

- Consistent and detailed symptom tracking is the cornerstone of effective chronic migraine management, enabling the identification of triggers, optimization of treatment plans, and informed discussions with healthcare providers.
- A significant paradigm shift is occurring with CGRP-targeted therapies, including monoclonal antibodies (mAbs) for prevention and oral gepants/nasal sprays for both acute and preventive use, offering highly effective and tailored options with generally favorable side effect profiles.
- Careful administration of acute medications is crucial, with new options like gepants and ditans providing alternatives to triptans, particularly for those with cardiovascular risks, and a strong emphasis on preventing Medication Overuse Headache (MOH).
- Caretakers play an indispensable role in supporting individuals with chronic migraine by creating personalized comfort kits, assisting with acute medication administration, and, critically, recognizing specific "red flag" symptoms that necessitate immediate emergency medical attention.

---

## Detailed Synthesis

### The Foundation of Migraine Management: Tracking and Personalization

Effective chronic migraine management begins with meticulous symptom tracking. For newly diagnosed individuals, this is the most powerful initial tool, helping to uncover unique migraine patterns, identify triggers (such as specific foods, stress, or sleep deprivation), and determine the optimal timing for acute medication. Recognizing prodromal symptoms through consistent tracking can significantly improve treatment effectiveness. Beyond diagnosis, tracking remains crucial for all patients and caretakers to objectively assess the efficacy of both acute and preventive treatments, noting frequency, severity, duration, associated symptoms, and any side effects. This data empowers patients and their healthcare providers to refine treatment strategies and incorporate holistic approaches like stress management or sleep hygiene. Caretakers can leverage this tracking data to personalize "comfort kits," which are essential supplements to prescribed acute medications, offering targeted sensory relief (e.g., weighted eye masks, noise-canceling headphones), non-pharmacological pain relief (e.g., topical gels), and practical support like hydration and gentle distractions.

### Targeted Therapies: The CGRP Revolution in Migraine Treatment

The landscape of chronic migraine treatment has been significantly advanced by CGRP-targeted therapies. These precision medications focus on Calcitonin Gene-Related Peptide (CGRP), a key molecule in migraine pain pathways, leading to more targeted action and often fewer systemic side effects than older treatments.

**Preventive Options:**
Monoclonal antibodies (mAbs) like Erenumab (Aimovig), Fremanezumab (Ajovy), Galcanezumab (Emgality), and Eptinezumab (Vyepti) are primarily used for prevention. Administered via subcutaneous injection (monthly or quarterly) or intravenous infusion (quarterly), they block either the CGRP receptor or the CGRP ligand itself. These are typically considered for patients with frequent migraines who haven't responded to traditional preventive treatments, with full therapeutic effects often observed within 2-3 months. Oral gepants, specifically Atogepant (Qulipta) and Rimegepant (Nurtec ODT, also approved for acute), also serve as daily or every-other-day preventive options, offering flexibility in pill form.

**Acute Treatment Options:**
Oral gepants such as Ubrogepant (Ubrelvy) and Rimegepant (Nurtec ODT), along with the nasal spray Zavegepant (Zavzpret), provide rapid, targeted relief for acute migraine attacks. These newer acute options are particularly beneficial for patients with cardiovascular concerns or those intolerant to triptans, as they do not cause vasoconstriction. Their targeted mechanism often results in fewer systemic side effects compared to older acute medications.

Common side effects across CGRP-targeted therapies can include injection site reactions (for mAbs), constipation (more common with erenumab and oral gepants), fatigue, nausea, and nasal discomfort (for sprays). Consistent tracking of these potential side effects is vital for ongoing treatment discussions with a neurologist.

### Optimizing Acute Attack Management and Avoiding Medication Overuse

Managing acute migraine attacks effectively requires a clear understanding of medication options and strict adherence to usage guidelines. Traditional acute treatments like **triptans** (e.g., sumatriptan) are effective for moderate to severe migraines but carry crucial limitations. They are contraindicated in patients with uncontrolled hypertension, heart disease, or stroke history due to their vasoconstrictive properties. More importantly, frequent use (typically more than 9 days per month) can lead to **Medication Overuse Headache (MOH)**, a paradoxical worsening of headaches that makes them harder to treat.

Newer acute options, such as **gepants** (e.g., ubrogepant, rimegepant) and **ditans** (e.g., lasmiditan), offer safer alternatives for many patients. Gepants are CGRP receptor antagonists that can be used more frequently without the same MOH risk and are safer for individuals with cardiovascular concerns. Ditans, while also non-vasoconstrictive, can cause side effects like dizziness and sedation. For all acute medications, prompt administration at the first sign of a migraine is key to maximizing effectiveness. Caretakers and patients must meticulously track medication use to prevent MOH and discuss efficacy and side effects with their physician to optimize the treatment regimen.

### Empowering Caretakers and Recognizing Emergency Signals

Caretakers play a pivotal role in supporting individuals with chronic migraine. Beyond creating personalized comfort kits, they are often on the front lines of acute attack management, needing to administer medications promptly, observe their effectiveness, and monitor for side effects. Crucially, caretakers must adhere strictly to prescribed dosages and frequency limits to prevent MOH.

However, a critical responsibility for caretakers is distinguishing a severe migraine from a medical emergency. Immediate medical attention (calling 911 or proceeding to the ER) is warranted for specific "red flag" symptoms:
-   **Sudden, severe "thunderclap" headache:** Reaching peak intensity within seconds to minutes, often described as the "worst headache of my life."
-   **Sudden, significant neurological changes:** Including weakness, numbness, difficulty speaking, vision changes (beyond typical aura), confusion, or loss of consciousness.
-   **Headache accompanied by fever, stiff neck, or rash.**
-   **Headache following head trauma.**
-   **New-onset headache in an individual over 50,** or concerning changes in a usual migraine pattern (sudden drastic shifts in frequency, intensity, or character).
Trusting instincts and seeking prompt evaluation for these symptoms can be life-saving. While waiting for help, keeping the patient calm and comfortable in a dark, quiet room is advisable, but no additional medication should be administered unless instructed by emergency personnel.

**week_topics:**
- Chronic Migraine Management
- CGRP Targeted Therapies
- Migraine Symptom Tracking
- Acute Migraine Treatment
- Medication Overuse Headache
- Caretaker Support for Migraine
- Migraine Emergency Signs
